- Home
- REPL vs MBWM Comparison
REPL vs MBWM Comparison
Compare REPL & MBWM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- MBWM
- Stock Information
- Founded
- REPL 2015
- MBWM 1997
- Country
- REPL United States
- MBWM United States
- Employees
- REPL N/A
- MBWM N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- MBWM Major Banks
- Sector
- REPL Health Care
- MBWM Finance
- Exchange
- REPL Nasdaq
- MBWM Nasdaq
- Market Cap
- REPL 757.8M
- MBWM 726.9M
- IPO Year
- REPL 2018
- MBWM 1997
- Fundamental
- Price
- REPL $9.35
- MBWM $46.41
- Analyst Decision
- REPL Strong Buy
- MBWM Buy
- Analyst Count
- REPL 7
- MBWM 2
- Target Price
- REPL $20.83
- MBWM $52.25
- AVG Volume (30 Days)
- REPL 1.1M
- MBWM 74.5K
- Earning Date
- REPL 08-07-2025
- MBWM 07-15-2025
- Dividend Yield
- REPL N/A
- MBWM 3.18%
- EPS Growth
- REPL N/A
- MBWM N/A
- EPS
- REPL N/A
- MBWM 4.80
- Revenue
- REPL N/A
- MBWM $222,296,000.00
- Revenue This Year
- REPL N/A
- MBWM $8.87
- Revenue Next Year
- REPL N/A
- MBWM $3.71
- P/E Ratio
- REPL N/A
- MBWM $9.69
- Revenue Growth
- REPL N/A
- MBWM 0.96
- 52 Week Low
- REPL $6.44
- MBWM $37.76
- 52 Week High
- REPL $17.00
- MBWM $52.98
- Technical
- Relative Strength Index (RSI)
- REPL 49.55
- MBWM 64.19
- Support Level
- REPL $8.92
- MBWM $44.85
- Resistance Level
- REPL $9.93
- MBWM $46.08
- Average True Range (ATR)
- REPL 0.52
- MBWM 1.09
- MACD
- REPL -0.08
- MBWM 0.24
- Stochastic Oscillator
- REPL 22.40
- MBWM 88.47
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
About MBWM Mercantile Bank Corporation
Mercantile Bank Corp operates as a bank holding company. It offers various commercial banking services to individuals, businesses, governmental units, and other institutions. These services include deposit products such as checking, savings, and term certificate accounts and lending products such as commercial, residential mortgage, and installment loans. The company generates revenue from interest and dividends earned on loans, securities, and other financial instruments.